$500 – $1,000 Paid Clinical Trials
440 studies
Short outpatient Phase 1 studies and multi-visit observational studies often compensate in the $500–$1,000 range.
Compensation amounts shown are typical ranges for this study type — not guaranteed amounts. Actual compensation is set by each study sponsor and documented in the informed consent form. ClinicalTrials.gov does not include a structured compensation field.
Showing 201–220 of 440 studies
Recruiting
Phase 1
A Study of Olomorasib (LY3537982) in Healthy Participants
Healthy
Eli Lilly and Company15 enrolled1 locationNCT07439250
Recruiting
Phase 1
A First-in-Human Phase 1 Single-Ascending Dose Study of ABCL575 in Healthy Participants
Healthy Volunteers
AbCellera Biologics Inc.40 enrolled1 locationNCT07108894
Recruiting
Phase 1
A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating Women
Healthy Participants
UCB Biopharma SRL15 enrolled2 locationsNCT06961747
Recruiting
Phase 1
A Study to Determine the Safety and Tolerability of AG-236 and How it is Absorbed, Broken Down, and Eliminated From the Body in Healthy Participants
Healthy Participants
Agios Pharmaceuticals, Inc.24 enrolled1 locationNCT07075640
Recruiting
Phase 1
A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Healthy Adults
Healthy
Pfizer92 enrolled1 locationNCT06994897
Recruiting
Phase 1Phase 2
Fecal Microbiota Transplantation for Patients With Autism Spectrum Disorder.
HealthyGastrointestinal DiseasesAutism Spectrum Disorder
Chang Gung Memorial Hospital60 enrolled1 locationNCT06290258
Recruiting
Phase 1Phase 2
RIG 101 Trial in Healthy Adults and Adults With Asthma
healthy adult participantsSafety and EfficacyAsthma Exacerbation
RIGImmune Inc.82 enrolled2 locationsNCT07488897
Recruiting
Phase 1
A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body in Healthy Adults
Healthy
Pfizer76 enrolled1 locationNCT07235150
Recruiting
Phase 1
A Food Effect Study to Evaluate the Relative Bioavailability of Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants
Healthy Participants
Trevi Therapeutics60 enrolled1 locationNCT07487740
Recruiting
Phase 1
Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease
Healthy Volunteers (HV)Parkinson's Disease (PD)
Vertero Therapeutics84 enrolled1 locationNCT07310264
Recruiting
Phase 1
A Phase I Study to Evaluate LIFE-001
Healthy Volunteers
LifeMine Therapeutics150 enrolled1 locationNCT06904807
Recruiting
Phase 1
A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants
Healthy Volunteers
Bristol-Myers Squibb32 enrolled1 locationNCT07422298
Recruiting
Phase 1
Single and Multiple Dose Pharmacokinetics (PK) of Aramchol From an Aramchol Meglumine Tablet
Healthy
Galmed Pharmaceuticals Ltd32 enrolled1 locationNCT07251712
Recruiting
Phase 1
A Drug-drug Interaction Study of Vorasidenib and a Combined Oral Contraceptive in Healthy Female Participants
Healthy Adult Female Participants
Institut de Recherches Internationales Servier (I.R.I.S.)28 enrolled1 locationNCT07235774
Recruiting
Phase 1
A Study to Learn How Different Forms of the Study Medicine Called Prazosin Are Taken up Into the Blood in Healthy Adults
Healthy
Pfizer72 enrolled1 locationNCT07231978
Recruiting
Phase 1
A Study（Phase I）of GS3-007a Dry Suspension in Healthy Chinese Adults
Healthy Adults
Changchun GeneScience Pharmaceutical Co., Ltd.32 enrolled1 locationNCT07473570
Recruiting
Phase 1
A Study of ENX-104 in Healthy Participants
Healthy Volunteers
Engrail Therapeutics INC12 enrolled1 locationNCT07472361
Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989 Following Subcutaneous or Intravenous Administration in Healthy Adult Participants
Healthy Participants
Incyte Corporation72 enrolled1 locationNCT07448155
Recruiting
Phase 1
Evaluation of the Safety, Tolerability and Pharmacokinetics of HY6725 in Healthy Adult Participants
Healthy
Newsoara Biopharma Co., Ltd.74 enrolled1 locationNCT07262281
Recruiting
Phase 1
Evaluation of the Safety, Tolerability and Pharmacokinetics of HY8931 in Healthy Adult Participants
Healthy
Newsoara Biopharma Co., Ltd.60 enrolled1 locationNCT07281703